Clinical Trial Update: Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI [NA]

View source ↗

Summary

This entry reports an ongoing clinical trial evaluating empagliflozin for cardiac and renal injury in ST-elevation myocardial infarction patients after primary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Reperfusion Injury
• St-elevation Myocardial Infarction

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Reperfusion Injury, Myocardial | NA | Status: UNKNOWN